Vasamed Stock

Vasamed EBIT

The EBIT of Vasamed (VSMD) as of Aug 16, 2026 is -2.74 M USD.

EBIT

-2.74 MUSD

Last updated:

In 2026, Vasamed's EBIT was -2.74 M USD, a % increase from the - USD EBIT recorded in the previous year.

The Vasamed EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (undefined USD)
Date
EBIT (undefined USD)
Jan 1, 2001
0.00 base
Jan 1, 2002
0.00 base
Jan 1, 2003
0.00 base
Jan 1, 2004
0.00 base
Jan 1, 2005
0.00 base
Jan 1, 2006
0.00 base
Jan 1, 2007
0.00 base
Jan 1, 2008
0.00 base
YEAREBIT (undefined USD)
2008 -
2007 -
2006 -
2005 -
2004 -
2003 -
2002 -
2001 -
2000 -
1999 -
1998 -
1997 -
1996 -
1995 -
1994 -
1993 -
1992 -
1991 -
1990 -
Access this data via the Eulerpool API

Vasamed Revenue

Vasamed Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2001
690,000.00 USD
-2.73 M USD
-3.40 M USD
Jan 1, 2002
1.58 M USD
-1.88 M USD
-1.85 M USD
Jan 1, 2003
2.13 M USD
-2.13 M USD
-2.28 M USD
Jan 1, 2004
1.07 M USD
-5.76 M USD
-6.42 M USD
Jan 1, 2005
1.39 M USD
-4.64 M USD
-6.85 M USD
Jan 1, 2006
2.00 M USD
-4.88 M USD
-6.48 M USD
Jan 1, 2007
3.13 M USD
-3.84 M USD
-5.63 M USD
Jan 1, 2008
3.14 M USD
-2.74 M USD
-2.92 M USD

Vasamed Margins

Vasamed stock margins

The Vasamed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vasamed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vasamed.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2001
55.15 %
-395.65 %
-492.75 %
Jan 1, 2002
69.62 %
-118.99 %
-117.09 %
Jan 1, 2003
14.92 %
-100.09 %
-107.29 %
Jan 1, 2004
-29.96 %
-539.04 %
-601.40 %
Jan 1, 2005
-4.98 %
-334.63 %
-494.37 %
Jan 1, 2006
19.08 %
-243.96 %
-323.58 %
Jan 1, 2007
42.77 %
-122.94 %
-180.10 %
Jan 1, 2008
55.15 %
-87.24 %
-93.27 %

Vasamed Stock analysis

What does Vasamed do? Vasamed Inc is an American company specializing in medical devices and diagnostics. It was founded in 1987 and is headquartered in St. Paul, Minnesota. Vasamed has become a leading manufacturer of devices for non-invasive vascular diagnostics and therapy, as well as for the assessment of vascular function and circulation. Vasamed's business model is based on selling and marketing medical devices and accessories to doctors, hospitals, and medical facilities worldwide. The company aims to provide its customers with innovative, high-quality medical devices and services that help improve patient diagnosis and treatment outcomes. In recent years, Vasamed has continuously expanded its product range. The company operates in various sectors, including the growing treatment options for circulatory and cardiovascular diseases. At the same time, the company also offers products and services to support science and research. In the field of "vascular diagnostics," Vasamed offers devices for determining circulatory disorders, such as laser taxis, ankle-brachial index systems, and laser doppler blood flow measurement devices. These devices are excellent for detecting diseases such as peripheral arterial occlusive disease (PAOD) or diabetes, which are known risk factors for the development of circulatory disorders. In the field of "endothelial function," Vasamed offers devices for measuring vascular health, such as the Endo-PAT system. This system is a non-invasive procedure for measuring the endothelial function of blood vessels, which is important for the prevention of cardiovascular diseases. In the "research and development projects" sector, the company collaborates with academic partners and industry researchers to develop new technologies and diagnostic and therapeutic procedures. Vasamed also participates in clinical trials and scientific conferences to present its research findings and products worldwide. Vasamed has a long history in medical diagnostics and therapy. The company has become one of the leading manufacturers of devices for non-invasive vascular diagnostics and therapy, as well as for the assessment of vascular function and circulation. Taking into account the experience and science that Vasamed has developed, the company aims to support medical professionals in the diagnosis and treatment of patients. Vasamed is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Vasamed's EBIT

Vasamed's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Vasamed's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Vasamed's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Vasamed’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Vasamed stock

EBIT of Vasamed is -2.74 M USD in 2026.

On Eulerpool you can find the complete historical development of EBIT Vasamed since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Vasamed historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Vasamed

All Key Metrics — Vasamed